MIA Co-Medical Director opens SMR Congress in USA
21 November 2019
Professor Georgina Long, Co-Medical Director of Melanoma Institute Australia, has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
Professor Long is the first Australian and the first female President of SMR.
In her opening address, she summed up recent breakthroughs and advances in melanoma research and welcomed delegates from around the globe. This year's SMR Congress will cover a range of melanoma research and treatment related areas including the melanoma microenvironment, advances in early detection and prevention of melanoma, targeted and immunotherapies and advances in acral, mucosal and uveal melanoma. Women in STEM will also be a focus for the Congress.
Professor Long's opening address was followed by a Keynote Presentation on Cellular conversations that control cancer by University of California researcher, Professor Thea Tlsty, and the formal Welcome Reception. SMR continues into the weekend, with a packed program including a number of poster presentations from Melanoma Institute Australia researchers and students.
In sessions prior to the official opening, Co-Medical Director Professor Richard Scolyer led discussions at an International Melanoma Pathology Study Group workshop and the day-long International Melanoma Pathology Symposium.
The opening of SMR comes just a day after Professor Long and Professor Richard Scolyer were recognised as among the world’s most influential in their respective fields by being named in the prestigious Clarivate Analytics 2019 Highly Cited Researchers List.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.
It was a massive weekend of Melanoma Marches with six Marches in: Bendigo, Canberra, Manly, Newcastle, Bunbury and Adelaide.
Weekend two hit the ground marching with Melanoma Marches in Wollongong, Townsville, Mandurah and Western Sydney.
Melanoma Institute Australia's annual fundraising initiative is all systems go!
The reported proliferation of illegal commercial solariums is costing lives and requires urgent government intervention.
15-year-old melanoma survivor Toby Rayner will lead Mount Gambier’s march against melanoma Julie-Ann Sams knows all too well that melanoma doesn’t discriminate.